• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Pembrolizumab Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5759553

Pertuzumab anti-HER2) a humanized monoclonal antibody and the first in the class of agents called the HER2 dimerization inhibitors impairs the ability of HER2 to bind to other members of the HER family. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Pembrolizumab, Inhibitor
Full Product Name
Pembrolizumab
Product Synonym Names
Pembrolizumab (anti-PD-1); anti-PD-1; MK-3475; lambrolizumab
Form/Format
Solid. Powder
Purity/Purification
98.1%
Preparation and Storage
Store at -20 degree C.
Molecular Weight
149000
Solubility
<1mg/ml refers to the product slightly soluble or insoluble
CAS Number
1374853-91-4
Target & IC50
PD-1: None
Cell Research
Objective: To examine the effect of high-dose steroid therapy on lymphocyte proliferation/functionality after stimulation with anti-CD3 in the presence of pembrolizumab. Concentrations: 5ug/mL. Method: Isolated PBMCs were pre-treated with prednisone (1nM - 1mM) before anti-CD3 stimulation. Anti-CD3-stimulated cells were then incubated with pembrolizumab and their proliferative capacity and IL-2 secretion ability were measured by carboxyfluorescein succinimidyl ester (CFSE) staining and ELISA. Cell lines: Human PBMCs
In vivo
In addition to Melanoma and Lung carcinoma, pembrolizumab has also demonstrated efficacy in other advanced solid tumors and hematologic malignancies. Pembrolizumab had an acceptable side-effect profile and showed antitumor activity in patients with advanced non-small-cell lung cancer[2]
Animal Research
Objective: To evaluate the pharmacokinetics and biodistribution of 89Zr-labeled Pembrolizumab Animal Model?Female ICR (CD-1) mice, Hsd: Sprague-Dawley outbred rats, NSG mice(humanized mice), hu- PBL-SCID mice(humanized mice)
Dry Ice Shipment
Extra charge fee may add to your shipping cost as dry ice is required to ship this product.

Product Categories/Family for Pembrolizumab, inhibitor

Testing Data of Pembrolizumab, inhibitor

Pembrolizumab Inhibitor – Cat# MBS5759553

Product References and Citations for Pembrolizumab, inhibitor

Khoja L, et al. Pembrolizumab. J Immunother Cancer. 2015 Aug 18;3:36.
Khoja L, et al. Pembrolizumab. J Immunother Cancer. 2015 Aug 18;3:36.
Garon EB, et al. Pembrolizumab for the treatment,of non-small-cell lung cancer. N Engl J Med. 2015 May 21;372(21):2018-28.
Garon EB, et al. Pembrolizumab for the treatment,of non-small-cell lung cancer. N Engl J Med. 2015 May 21;372(21):2018-28.

Other Notes

Small volumes of Pembrolizumab, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Pembrolizumab purchase

MBS5759553 is an inhibitor targeting Pembrolizumab.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000